Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
361 | 3 | ADENOVIRUS//MERKEL CELL CARCINOMA//POLYOMAVIRUS | 35836 |
818 | 2 | ONCOLYTIC VIRUS//GENE THERAPY//HUMAN GENE THERAPY | 12130 |
3933 | 1 | CYTOSINE DEAMINASE//SUICIDE GENE THERAPY//HERPES SIMPLEX VIRUS THYMIDINE KINASE | 1914 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CYTOSINE DEAMINASE | authKW | 973216 | 6% | 52% | 113 |
2 | SUICIDE GENE THERAPY | authKW | 952296 | 6% | 52% | 111 |
3 | HERPES SIMPLEX VIRUS THYMIDINE KINASE | authKW | 737984 | 4% | 55% | 82 |
4 | SUICIDE GENE | authKW | 735172 | 6% | 39% | 114 |
5 | THYMIDINE KINASE | authKW | 527361 | 8% | 21% | 152 |
6 | HSV TK | authKW | 505002 | 3% | 46% | 66 |
7 | GANCICLOVIR | authKW | 414280 | 8% | 16% | 157 |
8 | BYSTANDER EFFECT | authKW | 380162 | 6% | 19% | 119 |
9 | GENE THERAPY | authKW | 360116 | 30% | 4% | 568 |
10 | CANCER GENE THERAPY | journal | 275862 | 9% | 9% | 181 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Medicine, Research & Experimental | 15566 | 34% | 0% | 653 |
2 | Oncology | 10761 | 39% | 0% | 755 |
3 | Biotechnology & Applied Microbiology | 10528 | 32% | 0% | 610 |
4 | Genetics & Heredity | 10138 | 31% | 0% | 587 |
5 | Biochemistry & Molecular Biology | 387 | 16% | 0% | 306 |
6 | Urology & Nephrology | 198 | 4% | 0% | 71 |
7 | Gastroenterology & Hepatology | 194 | 4% | 0% | 72 |
8 | Surgery | 79 | 6% | 0% | 111 |
9 | Pharmacology & Pharmacy | 47 | 6% | 0% | 109 |
10 | Clinical Neurology | 34 | 4% | 0% | 67 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | UPJOHN 4713 | 65859 | 0% | 100% | 4 |
2 | SERV CHIRURG ABDOMINALE THORAC | 51448 | 0% | 63% | 5 |
3 | BIOL TUMEURS THER IE GEN | 49394 | 0% | 100% | 3 |
4 | BIOL GENET PATHOL IMMUNITAI | 32929 | 0% | 100% | 2 |
5 | CELL BIOL GENE THER Y | 32929 | 0% | 100% | 2 |
6 | CLIN MEDONCOL | 32929 | 0% | 100% | 2 |
7 | COOPERAT CLIN CANC | 32929 | 0% | 100% | 2 |
8 | GENE VECTOR | 31188 | 0% | 32% | 6 |
9 | THYROID STUDY UNIT | 28371 | 1% | 17% | 10 |
10 | MATSUNAGA CONTE PROSTATE CANC | 26882 | 0% | 23% | 7 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCER GENE THERAPY | 275862 | 9% | 9% | 181 |
2 | HUMAN GENE THERAPY | 96747 | 7% | 4% | 141 |
3 | GENE THERAPY | 66951 | 7% | 3% | 127 |
4 | JOURNAL OF GENE MEDICINE | 9586 | 2% | 2% | 29 |
5 | MOLECULAR THERAPY | 8210 | 2% | 1% | 43 |
6 | TUMOR TARGETING | 5104 | 0% | 10% | 3 |
7 | CURRENT GENE THERAPY | 4805 | 1% | 2% | 13 |
8 | CANCER RESEARCH | 3419 | 5% | 0% | 92 |
9 | CURRENT OPINION IN MOLECULAR THERAPEUTICS | 3162 | 1% | 1% | 13 |
10 | ANTICANCER RESEARCH | 1873 | 3% | 0% | 48 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYTOSINE DEAMINASE | 973216 | 6% | 52% | 113 | Search CYTOSINE+DEAMINASE | Search CYTOSINE+DEAMINASE |
2 | SUICIDE GENE THERAPY | 952296 | 6% | 52% | 111 | Search SUICIDE+GENE+THERAPY | Search SUICIDE+GENE+THERAPY |
3 | HERPES SIMPLEX VIRUS THYMIDINE KINASE | 737984 | 4% | 55% | 82 | Search HERPES+SIMPLEX+VIRUS+THYMIDINE+KINASE | Search HERPES+SIMPLEX+VIRUS+THYMIDINE+KINASE |
4 | SUICIDE GENE | 735172 | 6% | 39% | 114 | Search SUICIDE+GENE | Search SUICIDE+GENE |
5 | THYMIDINE KINASE | 527361 | 8% | 21% | 152 | Search THYMIDINE+KINASE | Search THYMIDINE+KINASE |
6 | HSV TK | 505002 | 3% | 46% | 66 | Search HSV+TK | Search HSV+TK |
7 | GANCICLOVIR | 414280 | 8% | 16% | 157 | Search GANCICLOVIR | Search GANCICLOVIR |
8 | BYSTANDER EFFECT | 380162 | 6% | 19% | 119 | Search BYSTANDER+EFFECT | Search BYSTANDER+EFFECT |
9 | GENE THERAPY | 360116 | 30% | 4% | 568 | Search GENE+THERAPY | Search GENE+THERAPY |
10 | 5 FLUOROCYTOSINE | 206913 | 2% | 32% | 39 | Search 5+FLUOROCYTOSINE | Search 5+FLUOROCYTOSINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |